The financial performance of the public biotech sector was remarkably buoyant last year, but a few worrying clouds hover on the horizon.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Enhancing cell growth and antibody production in CHO cells by siRNA knockdown of novel target genes
BMC Proceedings Open Access 04 December 2013
-
Establishment of a CpG island microarray for analyses of genome-wide DNA methylation in Chinese hamster ovary cells
Applied Microbiology and Biotechnology Open Access 22 October 2013
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Supplementary information
Supplementary Text and Figures
Supplementary Table 1 (XLS 153 kb)
Rights and permissions
About this article
Cite this article
Huggett, B., Lähteenmaki, R. Public biotech 2011—the numbers. Nat Biotechnol 30, 751–757 (2012). https://doi.org/10.1038/nbt.2320
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.2320
This article is cited by
-
The problem of bio-concepts: biopolitics, bio-economy and the political economy of nothing
Cultural Studies of Science Education (2017)
-
Establishment of a CpG island microarray for analyses of genome-wide DNA methylation in Chinese hamster ovary cells
Applied Microbiology and Biotechnology (2014)
-
Enhancing cell growth and antibody production in CHO cells by siRNA knockdown of novel target genes
BMC Proceedings (2013)